The PEXIVAS Trial: A conversation with Dr. Michael Walsh

  Рет қаралды 182

GlomCon Foundation

GlomCon Foundation

Күн бұрын

In this interview, Dr. Michael Walsh discusses the PEXIVAS trial that has changed the paradigm regarding how nephrologists manage ANCA associated vasculitis.
He discusses the new steroid taper protocol to minimize steroid related adverse effects, his thoughts on plasma exchange, as well as other exciting developments on the horizon.
Visit us 👇
www.glomcon.org
my.glomcon.org

Пікірлер
Overview of the PEXIVAS Study
27:34
vasculitisfoundation
Рет қаралды 238
APOL1 Mediated Kidney Disease: A Conversation with Dr. Kirk Campbell
15:26
لااا! هذه البرتقالة مزعجة جدًا #قصير
00:15
One More Arabic
Рет қаралды 26 МЛН
Опасность фирменной зарядки Apple
00:57
SuperCrastan
Рет қаралды 12 МЛН
Survive 100 Days In Nuclear Bunker, Win $500,000
32:21
MrBeast
Рет қаралды 117 МЛН
I'm Excited To see If Kelly Can Meet This Challenge!
00:16
Mini Katana
Рет қаралды 30 МЛН
SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
1:14:50
GlomCon Foundation
Рет қаралды 1,3 М.
CAR T Cell Therapy in Lupus: Promises and Challenges Explored
1:32:57
Lupus Europe
Рет қаралды 2,1 М.
Your Brain: Who's in Control? | Full Documentary | NOVA | PBS
53:33
NOVA PBS Official
Рет қаралды 3,3 МЛН
Nephrotic Syndrome
1:12:15
Ninja Nerd
Рет қаралды 170 М.
When A Gang Leader Confronted Muhammad Ali
11:43
Boxing After Dark
Рет қаралды 6 МЛН
When Should You See a Nephrologist
17:01
Dallas Nephrology Associates
Рет қаралды 24 М.
DNAJB9-Fibrillary Glomerulonephritis
5:06
GlomCon Foundation
Рет қаралды 292
لااا! هذه البرتقالة مزعجة جدًا #قصير
00:15
One More Arabic
Рет қаралды 26 МЛН